PT  - JOURNAL ARTICLE
AU  - Alexander, Lori
ED  - Saltz, Leonard
TI  - Updated Efficacy Results from XELOX1/NO16966, a Randomized Phase 3 Trial in First-Line Metastatic Colorectal Cancer
DP  - 2007 Sep 01
TA  - MD Conference Express
PG  - 22--26
VI  - 7
IP  - 3
4099  - http://mdc.sagepub.com/content/7/3/22.short
4100  - http://mdc.sagepub.com/content/7/3/22.full
AB  - This article discusses multiple studies using capecitabine plus oxaliplatin (XELOX), 5-fluorouracil (5-FU), leucovorin, and oxaliplatin (FOLFOX-4), and Infusional 5-FU/LV (FOLFOX-6), as well as the the MOSAIC and XELOX-1 Trials for the treatment of metastatic colorectal cancer.